20% of Big 4-audited IPOs report weaknesses in financial-reporting controls
Market Watch published a piece about an SEC proposal to exempt some development-stage biotech and medical device companies from getting an auditor’s opinion on their internal controls. Commissioner Hester Peirce spoke of her support for the proposal at Mendoza's 2019 CARE conference, saying that investors want their money to go to research and growing the company and not to auditors.
- Published
Related News & Stories
Mendoza
Redefining Business Success
Top B Corp CEO Anne St. Peter to share how purpose and profit can exist on a level playing field at Dean’s Speaker Series on Nov. 13, 2026.
Alumni Impact
A Career as a Manifesto for the Power of Community
As a modern marketer, Mendoza alum Roxy Young has rolled with technological changes by keeping her eyes on the community.
Faith
Where Faith Meets the Global Economy
Rev. Oliver Williams’ lifelong mission has been to prove that ethical conviction belongs at the heart of business.